Document is current
Any future updates will be listed below
-
Authors
Drucker, Daniel J. https://orcid.org/0000-0001-6688-8127
-
Funding
Funding for this research was provided by:
Gouvernement du Canada | Instituts de Recherche en Santé du Canada | CIHR Skin Research Training Centre (154321)
- License Information
-
More Information
Article History
Received: 22 August 2025
Accepted: 14 November 2025
First Online: 2 January 2026
Competing interests
: D.J.D. has received financial remuneration from Alnylam, Amgen, AstraZeneca, Crinetics, Eli Lilly, Insulet, Kallyope, Metsera, Pfizer and Sanofi for consulting and from Novo Nordisk for speaking, and Mt. Sinai Hospital receives investigator-initiated grant support from Amgen, Eli Lilly, Novo Nordisk and Zealand Pharma for preclinical studies in the Drucker lab.
